Trial Information

Summary: A Multicenter, Double-Blind, Placebo-Controlled, Fixed-Dose, 8-week Evaluation of the Efficacy and Safety of Lamotrigine in the Treatment of Bipolar Disorder Patients Currently Experiencing a Major Depressive Episode.

Study Description
This study is evaluating how safe and effective Lamotrigine is to treat Bipolar Depression. Lamotrigine has not yet been approved for the treatment of Bipolar Depression. However, it is an approved medication, on the market, to prevent seizures. Participants will have a 50/50 chance of receiving Lamotrigine or Placebo for a total of 8 weeks. There are a total of 10 visits. Participants are paid $50.00 for each completed visit. You must be living in San Diego, CA and plan on being available for 10 continuous weeks.

Study Criteria
Participants must be:

• at least 18 years old
• diagnosed with Bipolar Disorder
• currently Depressed for at least 8 weeks
• able to discontinue the use of all other psychiatric medications

Participants must not have been treated with Lamotrigine previously.

If you would like to learn more about participating in this study, please send an e-mail message using the form below.